HIV/AIDS

Buprenorphine and methadone — while linked to increased risk of serious side effects — are more beneficial than harmful when combined with benzodiazepines or other central nervous system depressants for opioid addiction care.

Truvada showed efficacy and safety in HIV-susceptible teenage boys — so as long as they kept up with treatment.

The answer could be found in tick saliva.

A study found that the demographic characteristics of patients who failed to initiate ART within 2 years of entering care were not as important as clinical factors.

The rates of viral rebound in people with long-term viral suppression on first-line regimens have become "extremely low," according to a study.

While the national split is a significant jump from previously reported rates, the degrees of the success vary in different parts of the country, Barry S. Zingman, MD, Medical Director, AIDS Center, Montefiore Health System, told MD Magazine.

Surveyed LGB adults also reported notably greater rates of heart conditions with more lesbian and bisexual women reporting strokes and heart attacks than heterosexual women, and more gay and bisexual men reporting chest pain related to heart disease than heterosexual men.

Catch up on or relive the biggest headlines in healthcare of the past month.

The review is part of a multi-pronged effort to curb opioid abuse nationwide.

The UNC-based research covered the period from January 2003 to December 2012, when most patients in the study were not covered by the most recent federal guidelines pertaining to HIV treatment.

Neurotoxin EB-001's fast treatment start-up and shorter duration could make for a different focal pain reliever.

“This study tells us that the opioid epidemic has made people sicker and killed more people, in spite of all the care we can provide in the ICU, including mechanical ventilation, acute dialysis, life support and round-the-clock care."

Within a week of a Presidential committee tasked with overseeing the epidemic, a study has shown national addiction drug death rates are understated.

RBP-6000, a injectable buprenorphine for adult moderate-to-severe OUD patients, was submitted for new drug application in May with major consideration to a phase 3 efficacy and safety study.

Each of these 5 long-acting treatments holds the potential to change the way doctors treat their patients.

In fact, little is clinically known about the effects of combining the two therapies.

HIV prevention needs of adolescents may differ from those of adults, but their treatments may not have to.

Women are more likely to participate in riskier sexual behaviors that can cause HIV-infection, with non-Hispanic black women representing the highest-risk.

As the average age of HIV patients has risen, difficulties in physical abilities compared to the norm have become a new obstacle.

Cesarean sections can lead to higher rates of respiratory distress syndrome and transient tachyprea.

Researchers at the University of North Carolina are beginning to combine a latency reversal agent with treatments that would destroy latent forms of HIV.

Switching ART regimens could mean the difference between poor health outcomes and effective viral suppression.

The agency plans to provide additional funding to further the cause later this summer.

NIH researchers have successfully identified and blocked a previously undiscovered step in the HIV infection process.

How the FDA has bolstered its policies and rulings on opioid products in just 2 months under commissioner Scott Gottlieb.

The monoclonal antibody — a once-weekly injection endorsed by actor Charlie Sheen — has been undergoing current clinical phases for over 2 years.

As with other viruses, Zika may increase rates that infected mothers give HIV to their babies, despite medications.

The method has been commonly used to identify rare drug-resistant variants of the HIV virus.

Paid patients experienced a 4% increase in viral suppression.

L-glutamine is the first SCD treatment approved for pediatric patients, and the first adult treatment approved in nearly 20 years.